Patents by Inventor Daniel C. Weinstein

Daniel C. Weinstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Translation initiation factor 4AIII, and methods of use thereof
    Publication number: 20030181704
    Abstract: The present invention provides a vertebrate translation initiation factor (eIF-4AIII), that plays a role in the differentiation of an embryonic cell to an epidermal cell. This translation initiation factor interacts with BMP-4 in a positive regulatory loop. The nucleic acid and amino acid sequences are also disclosed. Also disclosed are methods of using the translation initiation factor, nucleic acids encoding the same, and corresponding antibodies and the like.
    Type: Application
    Filed: May 5, 2003
    Publication date: September 25, 2003
    Applicant: Rockefeller University, The
    Inventors: Ali Hemmati-Brivanlou, Daniel C. Weinstein
  • Translation initiation factor 4AIII, and methods of use thereof
    Publication number: 20010025100
    Abstract: The present invention provides a vertebrate translation initiation factor (eIF-4AIII), that plays a role in the differentiation of an embryonic cell to an epidermal cell. This translation initiation factor interacts with BMP-4 in a positive regulatory loop. The nucleic acid and amino acid sequences are also disclosed. Also disclosed are methods of using the translation initiation factor, nucleic acids encoding the same, and corresponding antibodies and the like.
    Type: Application
    Filed: January 5, 2001
    Publication date: September 27, 2001
    Applicant: The Rockefeller University
    Inventors: Ali Hemmati-Brivanlou, Daniel C. Weinstein
  • Antibodies to a novel src-family kinase
    Patent number: 6291651
    Abstract: The present invention provides a unique src-family kinase (SFK) that plays a key role in the transformation of early-stage embryonic cells to mesodermal cells. Furthermore, this src-family kinase is likely to be a proto-oncogene. The nucleic acid and amino acid sequences are disclosed.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: September 18, 2001
    Assignee: The Rockerfeller University
    Inventors: Ali Hemmait-Brivanlou, Daniel C. Weinstein
  • Translation initiation factor 4AIII and methods of use thereof
    Patent number: 6197947
    Abstract: The present invention provides a vertebrate translation initiation factor (eIF-4AIII), that plays a role in the differentiation of an embryonic cell to an epideimal cell. This translation initiation factor interacts with BMP-4 in a positive regulatory loop. The nucleic acid and amino acid sequences are also disclosed. Also disclosed are methods of using the translation initiation factor, nucleic acids encoding the same, and corresponding antibodies and the like.
    Type: Grant
    Filed: May 25, 1999
    Date of Patent: March 6, 2001
    Assignee: The Rockefeller University
    Inventors: Ali Hemmati-Brivanlou, Daniel C. Weinstein
  • Src-family kinase and methods of use thereof
    Patent number: 5952213
    Abstract: The present invention provides a unique src-family kinase (SFK) that plays a key role in the transformation of early-stage embryonic cells to mesodermal cells. Furthermore, this src-family kinase is likely to be a proto-oncogene. The nucleic acid and amino acid sequences are disclosed.
    Type: Grant
    Filed: January 13, 1998
    Date of Patent: September 14, 1999
    Assignee: The Rockefeller University
    Inventors: Ali Hemmati-Brivanlou, Daniel C. Weinstein